Literature DB >> 31024197

A/H1N1/09 Influenza is Associated With High Mortality in Liver Cirrhosis.

Madhumita Premkumar1, Devaraja Devurgowda1, Shivani Dudha1, Rakhi Maiwall1, Chhagan Bihari2, Shrruti Grover2, Ekta Gupta3, Sachin Kumar4, Shiv K Sarin1.   

Abstract

BACKGROUND/AIMS: A/H1N1/09 influenza is associated with a high risk of complications in patients with chronic diseases. In view of patients with cirrhosis being recognized as another high-risk group for influenza morbidity and mortality, we report a cluster of suspected A/H1N1/09 infection in 110 patients admitted to a hepatology intensive care unit.
METHODS: The pattern of spread, clinical outcome, and respiratory parameters of A/H1N1/09 of 22 positive cirrhotic patients were compared with those from a control group of 88 patients with chronic liver disease (CLD) with influenza-like pneumonia who tested negative for A/H1N1/09.
RESULTS: A/H1N1/09 infection was confirmed in 22 (20%) patients. Eighteen of 22 (81.8%) CLD patients with A/H1N1/09 died of pneumonia and acute respiratory distress syndrome despite timely antiviral treatment. In contrast, only 35 (40%)of the control group of cirrhotic patients without A/H1N1/09 died. On univariate analysis, age > 45 years [OR 1.3; 95% CI 1.1-5.7, (P = 0.054)], encephalopathy > grade 2 [OR 5.4; 95% CI 2.8-12.3, (P = 0.042)], serum bilirubin >8 mg/dl [OR 2.1; 95% CI 1.8-12.3, (P = 0.052)], serum creatinine >1.8 mg/dl [OR 2.8; 95% CI 1.9-9.2, (P = 0.042)], PaO2/FiO2 ratio <200 [OR 4.5; 95% CI 3.1-18.5, (P = 0.026)] and INR > 2.5 [OR 2.2; 95% CI 1.8-6.7, (P = 0.032)] were risk factors for mortality at presentation. However, on multivariate analysis only PaO2/FiO2 ratio <200 and serum creatinine >1.8 mg/dl remained predictors of mortality. Secondary infections, whether fungal or bacterial, were noted to be independent risk factors for disease severity in patients with cirrhosis.
CONCLUSION: Early detection and referral, and early antiviral treatment with a strict control of nosocomial spread is essential in patients with cirrhosis during epidemic influenza.

Entities:  

Keywords:  AKI, Acute Kidney Injury; APACHE II, Acute Physiologic Assessment and Chronic Health Evaluation II; ARDS, Acute Respiratory Distress Syndrome; CLD, Chronic Liver Disease; CTP, Child Turcotte Pugh Score; CXR, Chest Radiograph; H1N1 influenza; ICU, Intensive Care Unit; ILI, Influenza Like Illness; INR, International Normalized Ratio; MELD, Model for End-Stage Liver Disease; NASH, Non Alcoholic Steatohepatitis; PCR, Polymerase Chain Reaction; SOFA, Sequential Organ Failure Score; critical care in liver disease; pneumonia; ventilatory support

Year:  2018        PMID: 31024197      PMCID: PMC6477137          DOI: 10.1016/j.jceh.2018.04.006

Source DB:  PubMed          Journal:  J Clin Exp Hepatol        ISSN: 0973-6883


  20 in total

Review 1.  Update on immunizations in solid organ transplant recipients: what clinicians need to know.

Authors:  R K Avery; M Michaels
Journal:  Am J Transplant       Date:  2007-12-18       Impact factor: 8.086

Review 2.  Influenza in immunosuppressed populations: a review of infection frequency, morbidity, mortality, and vaccine responses.

Authors:  Ken M Kunisaki; Edward N Janoff
Journal:  Lancet Infect Dis       Date:  2009-08       Impact factor: 25.071

3.  Efficacy of influenza vaccination in adult liver transplant recipients.

Authors:  N M Soesman; G F Rimmelzwaan; N J Nieuwkoop; W E Beyer; H W Tilanus; M H Kemmeren; H J Metselaar; R A de Man; A D Osterhaus
Journal:  J Med Virol       Date:  2000-05       Impact factor: 2.327

4.  Kupffer cell-dependent hepatitis occurs during influenza infection.

Authors:  Noelle K Polakos; Judith C Cornejo; Debbie A Murray; Kate O Wright; John J Treanor; I Nicholas Crispe; David J Topham; Robert H Pierce
Journal:  Am J Pathol       Date:  2006-04       Impact factor: 4.307

Review 5.  Influenza infection in patients before and after liver transplantation.

Authors:  A Duchini; R M Hendry; D C Redfield; P J Pockros
Journal:  Liver Transpl       Date:  2000-09       Impact factor: 5.799

6.  Multiorgan distribution of human influenza A virus strains observed in a mouse model.

Authors:  T Fislová; M Gocník; T Sládková; V Durmanová; J Rajcáni; E Varecková; V Mucha; F Kostolanský
Journal:  Arch Virol       Date:  2009-02-03       Impact factor: 2.574

7.  Influenza vaccination in orthotopic liver transplant recipients: absence of post administration ALT elevation.

Authors:  Adeyemi Lawal; Chris Basler; Andrea Branch; Julio Gutierrez; Myron Schwartz; Thomas D Schiano
Journal:  Am J Transplant       Date:  2004-11       Impact factor: 8.086

8.  Cell-mediated immune response to influenza vaccination in lung transplant recipients.

Authors:  Peter J Mazzone; Sherif B Mossad; Steven D Mawhorter; Atul C Mehta; Janet R Mauer
Journal:  J Heart Lung Transplant       Date:  2004-10       Impact factor: 10.247

9.  Detection of influenza A(H1N1)v virus by real-time RT-PCR.

Authors:  M Panning; M Eickmann; O Landt; M Monazahian; S Olschläger; S Baumgarte; U Reischl; J J Wenzel; H H Niller; S Günther; B Hollmann; D Huzly; J F Drexler; A Helmer; S Becker; B Matz; Am Eis-Hübinger; C Drosten
Journal:  Euro Surveill       Date:  2009-09-10

10.  Systemic viral infections and collateral damage in the liver.

Authors:  David H Adams; Stefan G Hubscher
Journal:  Am J Pathol       Date:  2006-04       Impact factor: 4.307

View more
  8 in total

1.  The Clinical Impact of Cirrhosis on the Hospital Outcomes of Patients Admitted With Influenza Infection: Propensity Score Matched Analysis of 2011-2017 US Hospital Data.

Authors:  David U Lee; Gregory H Fan; David J Hastie; Vibhav N Prakasam; Elyse A Addonizio; Ryan R Ahern; Kristen J Seog; Raffi Karagozian
Journal:  J Clin Exp Hepatol       Date:  2021-02-04

2.  Comparison of different prognostic scores for patients with cirrhosis hospitalized with SARS-CoV-2 infection.

Authors:  Manuel Mendizabal; Ezequiel Ridruejo; Federico Piñero; Margarita Anders; Martín Padilla; Luis G Toro; Aldo Torre; Pedro Montes; Alvaro Urzúa; Esteban Gonzalez Ballerga; María Dolores Silveyra; Douglas Michelato; Javier Díaz; Mirta Peralta; Josefina Pages; Sandro Ruiz García; Isabel Gutierrez Lozano; Yuridia Macias; Daniel Cocozzella; Norberto Chavez-Tapia; Martín Tagle; Alejandra Dominguez; Adriana Varón; Emilia Vera Pozo; Fátima Higuera-de la Tijera; Carla Bustios; Damián Conte; Nataly Escajadillo; Andrés J Gómez; Laura Tenorio; Mauricio Castillo Barradas; Maria Isabel Schinoni; Fernando Bessone; Fernando Contreras; Leyla Nazal; Abel Sanchez; Matías García; Julia Brutti; María Cecilia Cabrera; Godolfino Miranda-Zazueta; German Rojas; Maximo Cattaneo; Graciela Castro-Narro; Fernando Rubinstein; Marcelo O Silva
Journal:  Ann Hepatol       Date:  2021-04-14       Impact factor: 2.400

3.  Influenza vaccination uptake and factors influencing vaccination decision among patients with chronic kidney or liver disease.

Authors:  Michael Eder; Haris Omic; Jana Gorges; Florian Badt; Zeljko Kikic; Marcus D Saemann; Allison Tong; David Bauer; Georg Semmler; Thomas Reiberger; Heimo Lagler; Bernhard Scheiner
Journal:  PLoS One       Date:  2021-04-13       Impact factor: 3.240

Review 4.  Cytokine Storm of COVID-19 and Its Impact on Patients with and without Chronic Liver Disease.

Authors:  Madhumita Premkumar; Chandan Kumar Kedarisetty
Journal:  J Clin Transl Hepatol       Date:  2021-04-19

Review 5.  Vaccination in Chronic Liver Disease: An Update.

Authors:  Joseph J Alukal; Haider A Naqvi; Paul J Thuluvath
Journal:  J Clin Exp Hepatol       Date:  2021-12-08

6.  Machine learning for emerging infectious disease field responses.

Authors:  Han-Yi Robert Chiu; Chun-Kai Hwang; Shey-Ying Chen; Fuh-Yuan Shih; Hsieh-Cheng Han; Chwan-Chuen King; John Reuben Gilbert; Cheng-Chung Fang; Yen-Jen Oyang
Journal:  Sci Rep       Date:  2022-01-10       Impact factor: 4.379

Review 7.  From advanced disease to transplantation: an overview of the liver at the time of COVID-19 pandemic.

Authors:  Giovanni Vitale; Stefano Gitto; Fabio Marra; Maria Cristina Morelli
Journal:  Intern Emerg Med       Date:  2021-07-10       Impact factor: 5.472

8.  A prediction model for 30-day deaths of cirrhotic patients in intensive care unit hospitalization.

Authors:  Yuyuan Hu; Dongling Chen; Qian Li; Guichun Yin; Xianjun Zhang; Yachun Wang
Journal:  Medicine (Baltimore)       Date:  2022-02-04       Impact factor: 1.889

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.